250 related articles for article (PubMed ID: 30697902)
21. Genome-wide association study reveals a novel locus for asthma with severe exacerbations in diverse populations.
Herrera-Luis E; Espuela-Ortiz A; Lorenzo-Diaz F; Keys KL; Mak ACY; Eng C; Huntsman S; Villar J; Rodriguez-Santana JR; Burchard EG; Pino-Yanes M
Pediatr Allergy Immunol; 2021 Jan; 32(1):106-115. PubMed ID: 32841424
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetic analysis of GLCCI1 in three north European pediatric asthma populations with a reported use of inhaled corticosteroids.
Vijverberg SJ; Tavendale R; Leusink M; Koenderman L; Raaijmakers JA; Postma DS; Koppelman GH; Turner SW; Mukhopadhyay S; Palmer CN; Maitland-van der Zee AH
Pharmacogenomics; 2014 Apr; 15(6):799-806. PubMed ID: 24897287
[TBL] [Abstract][Full Text] [Related]
23. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma.
Tantisira KG; Silverman ES; Mariani TJ; Xu J; Richter BG; Klanderman BJ; Litonjua AA; Lazarus R; Rosenwasser LJ; Fuhlbrigge AL; Weiss ST
J Allergy Clin Immunol; 2007 Dec; 120(6):1285-91. PubMed ID: 17980418
[TBL] [Abstract][Full Text] [Related]
24. Epigenome-wide association study of lung function in Latino children and youth with asthma.
Herrera-Luis E; Li A; Mak ACY; Perez-Garcia J; Elhawary JR; Oh SS; Hu D; Eng C; Keys KL; Huntsman S; Beckman KB; Borrell LN; Rodriguez-Santana J; Burchard EG; Pino-Yanes M
Clin Epigenetics; 2022 Jan; 14(1):9. PubMed ID: 35033200
[TBL] [Abstract][Full Text] [Related]
25. The upper-airway microbiome as a biomarker of asthma exacerbations despite inhaled corticosteroid treatment.
Perez-Garcia J; González-Carracedo M; Espuela-Ortiz A; Hernández-Pérez JM; González-Pérez R; Sardón-Prado O; Martin-Gonzalez E; Mederos-Luis E; Poza-Guedes P; Corcuera-Elosegui P; Callero A; Sánchez-Machín I; Korta-Murua J; Pérez-Pérez JA; Villar J; Pino-Yanes M; Lorenzo-Diaz F
J Allergy Clin Immunol; 2023 Mar; 151(3):706-715. PubMed ID: 36343772
[TBL] [Abstract][Full Text] [Related]
26. Daily vs. intermittent inhaled corticosteroids for recurrent wheezing and mild persistent asthma: a systematic review with meta-analysis.
Rodrigo GJ; Castro-Rodríguez JA
Respir Med; 2013 Aug; 107(8):1133-40. PubMed ID: 23769720
[TBL] [Abstract][Full Text] [Related]
27. Novel genetic variants associated with inhaled corticosteroid treatment response in older adults with asthma.
Wang AL; Lahousse L; Dahlin A; Edris A; McGeachie M; Lutz SM; Sordillo JE; Brusselle G; Lasky-Su J; Weiss ST; Iribarren C; Lu MX; Tantisira KG; Wu AC
Thorax; 2023 May; 78(5):432-441. PubMed ID: 35501119
[TBL] [Abstract][Full Text] [Related]
28. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
[TBL] [Abstract][Full Text] [Related]
29. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
30. Inhaled corticosteroids in children: use and effects of early treatment on asthma and lung function. Prevalence of asthma and the impact of severity in early life on later asthma in childhood.
Devulapalli CS
Clin Respir J; 2008 Oct; 2(4):247-8. PubMed ID: 20298343
[TBL] [Abstract][Full Text] [Related]
31. Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma.
van Aalderen WM; Grigg J; Guilbert TW; Roche N; Israel E; Martin RJ; Colice G; Postma DS; Hillyer EV; Burden A; Thomas V; von Ziegenweidt J; Price D
J Allergy Clin Immunol Pract; 2015; 3(5):721-31.e16. PubMed ID: 26032474
[TBL] [Abstract][Full Text] [Related]
32. CTNNA3 and SEMA3D: Promising loci for asthma exacerbation identified through multiple genome-wide association studies.
McGeachie MJ; Wu AC; Tse SM; Clemmer GL; Sordillo J; Himes BE; Lasky-Su J; Chase RP; Martinez FD; Weeke P; Shaffer CM; Xu H; Denny JC; Roden DM; Panettieri RA; Raby BA; Weiss ST; Tantisira KG
J Allergy Clin Immunol; 2015 Dec; 136(6):1503-1510. PubMed ID: 26073756
[TBL] [Abstract][Full Text] [Related]
33. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
[TBL] [Abstract][Full Text] [Related]
34. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.
Quon BS; Fitzgerald JM; Lemière C; Shahidi N; Ducharme FM
Cochrane Database Syst Rev; 2010 Dec; (12):CD007524. PubMed ID: 21154378
[TBL] [Abstract][Full Text] [Related]
35. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.
Quon BS; Fitzgerald JM; Lemière C; Shahidi N; Ducharme FM
Cochrane Database Syst Rev; 2010 Oct; (10):CD007524. PubMed ID: 20927759
[TBL] [Abstract][Full Text] [Related]
36. Racial/Ethnic-Specific Differences in the Effects of Inhaled Corticosteroid Use on Bronchodilator Response in Patients With Asthma.
Samedy-Bates LA; Oh SS; Nuckton TJ; Elhawary JR; White M; Elliot T; Zeiger AM; Eng C; Salazar S; LeNoir MA; Meade K; Farber HJ; Serebrisky D; Brigino-Buenaventura E; Rodriguez-Cintron W; Bibbins-Domingo K; Kumar R; Thyne S; Borrell LN; Rodriguez-Santana JR; Pino-Yanes M; Burchard EG
Clin Pharmacol Ther; 2019 Nov; 106(5):1133-1140. PubMed ID: 31209858
[TBL] [Abstract][Full Text] [Related]
37. CMTR1 is associated with increased asthma exacerbations in patients taking inhaled corticosteroids.
Dahlin A; Denny J; Roden DM; Brilliant MH; Ingram C; Kitchner TE; Linneman JG; Shaffer CM; Weeke P; Xu H; Kubo M; Tamari M; Clemmer GL; Ziniti J; McGeachie MJ; Tantisira KG; Weiss ST; Wu AC
Immun Inflamm Dis; 2015 Dec; 3(4):350-9. PubMed ID: 26734457
[TBL] [Abstract][Full Text] [Related]
38. Corticosteroid plus β
Wang G; Zhang X; Zhang HP; Wang L; Kang Y; Barnes PJ; Wang G
Respir Res; 2017 Dec; 18(1):203. PubMed ID: 29207999
[TBL] [Abstract][Full Text] [Related]
39. Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients.
Jin Y; Hu D; Peterson EL; Eng C; Levin AM; Wells K; Beckman K; Kumar R; Seibold MA; Karungi G; Zoratti A; Gaggin J; Campbell J; Galanter J; Chapela R; Rodríguez-Santana JR; Watson HG; Meade K; Lenoir M; Rodríguez-Cintrón W; Avila PC; Lanfear DE; Burchard EG; Williams LK
J Allergy Clin Immunol; 2010 Sep; 126(3):618-25.e1-2. PubMed ID: 20673984
[TBL] [Abstract][Full Text] [Related]
40. Predictors for failed dose reduction of inhaled corticosteroids in childhood asthma.
Li AM; Tsang TW; Lam HS; Sung RY; Chang AB
Respirology; 2008 May; 13(3):400-7. PubMed ID: 18399863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
